Polycystic ovary syndrome (PCOS) is a very common disorder that occurs up t
o 10% of premenopausal women. Although PCOS is known to be associated with
a higher reproductive morbility and increased risk of hormone dependent-can
cer, its diagnosis is particularly important because PCOS is strongly linke
d to insulin resistance. This involves a major risk of early metabolic and
cardiovascular complications. On the other band, the prevalence of metaboli
c disorders associated with insulin resistance is higher in-family members
of patients with PCOS than in those of normal women, which suggests that th
e treatment of this syndrome should be preventive rather than symptomatic.
For that reason, PCOS might be considered a signal of a family disorder, a
route to diabetes and a public health problem (Rev Med Chile 2001; 129: 805
-12).